Artificial intelligence (AI) technology is being used in gene editing, leading to a prediction of societal evolution. AI pioneer Mustafa Suleyman argues in his book that AI and synthetic biology will empower humankind while presenting unprecedented risks. AI has been used for embryo selection, with some fertility clinics offering the choice of eye color and avoiding genetic diseases. This technology has evolved into polygenic risk score (PRS) selection, which provides a summary of an individual’s risk of a particular condition or trait. The first PRS baby was born in 2020. One woman claims to be carrying “the first baby who will be selected for his intelligence,” though some experts call the process a scam. The rapid development of AI in gene editing has led to concerns about the ethical and societal implications of these technologies. The article discusses the impact of AI on gene editing and fertility clinics, as well as the potential risks and benefits associated with these advancements. It also explores the increasing use of AI in embryo selection and the potential for future developments in this field. The ethical concerns surrounding the use of AI in gene editing and fertility clinics are also addressed, highlighting the need for careful consideration of the societal impact of these technologies.